Ravinder Dhawan is currently the Vice President and Head of Global HTA, Value & Evidence at Pfizer, a position held since 2024. They previously served as Vice President & Head of CORE at Merck from 2021 to 2024 and have held several leadership roles at other notable organizations including The Janssen Pharmaceutical Companies of Johnson & Johnson and Sanofi. With a robust academic background that includes a PhD in Health Economics from the University of Connecticut, Ravinder has also contributed to the field as an adjunct assistant professor at the University of Western Ontario. Their extensive experience in health economics and market access spans several decades, showcasing their expertise in various therapeutic areas including oncology and diabetes.
This person is not in any teams
This person is not in any offices